We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$33.4B
AUM Growth
+$2.35B
Cap. Flow
-$652M
Cap. Flow %
-1.96%
Top 10 Hldgs %
25.9%
Holding
1,133
New
72
Increased
394
Reduced
425
Closed
76

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$242M
2
AMZN icon
Amazon
AMZN
+$69.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$67M
4
UBS icon
UBS Group
UBS
+$59.2M
5
LW icon
Lamb Weston
LW
+$58.5M

Top Sells

Rank Stock Value
1
AXNX
Axonics, Inc. Common Stock
AXNX
+$105M
2
AAPL icon
Apple
AAPL
+$87.1M
3
APTV icon
Aptiv
APTV
+$80.3M
4
TSCO icon
Tractor Supply
TSCO
+$80M
5
DE icon
Deere & Co
DE
+$78.5M

Sector Composition

Rank Sector Weight
1 Technology 35.56%
2 Healthcare 16.52%
3 Consumer Discretionary 11.68%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
51
Intuit
INTU
$91.1B
$140M 0.42%
215,081
+4,498
+2% +$2.87M
BMY icon
52
Bristol-Myers Squibb
BMY
$130B
$136M 0.41%
2,516,437
+155,632
+7% +$7.93M
WDAY icon
53
Workday
WDAY
$41.7B
$136M 0.41%
500,280
+21,672
+5% +$6.17M
EW icon
54
Edwards Lifesciences
EW
$49B
$131M 0.39%
1,375,935
+7,173
+0.5% +$603K
UNP icon
55
Union Pacific
UNP
$173B
$131M 0.39%
530,955
+31,287
+6% +$7.7M
ROP icon
56
Roper Technologies
ROP
$40.4B
$124M 0.37%
221,669
-5,958
-3% -$3.25M
PGR icon
57
Progressive
PGR
$128B
$123M 0.37%
595,412
+124,528
+26% +$23.1M
JNJ icon
58
Johnson & Johnson
JNJ
$644B
$122M 0.37%
772,986
-285,219
-27% -$45.4M
BKNG icon
59
Booking.com
BKNG
$157B
$122M 0.37%
841,175
-320,275
-28% -$45.6M
RSG icon
60
Republic Services
RSG
$68.1B
$120M 0.36%
629,155
+24,086
+4% +$4.27M
BDX icon
61
Becton Dickinson
BDX
$46.3B
$118M 0.35%
475,513
-78,961
-14% -$18.9M
VEEV icon
62
Veeva Systems
VEEV
$33.7B
$115M 0.35%
497,606
-17,637
-3% -$3.81M
MCO icon
63
Moody's
MCO
$84.1B
$109M 0.33%
277,767
-15,820
-5% -$6.1M
UBS icon
64
UBS Group
UBS
$171B
$109M 0.33%
3,535,785
+2,003,977
+131% +$59.2M
EOG icon
65
EOG Resources
EOG
$77.2B
$108M 0.32%
842,917
+248,838
+42% +$29M
GPN icon
66
Global Payments
GPN
$24.1B
$107M 0.32%
801,987
-192,873
-19% -$25.5M
ECL icon
67
Ecolab
ECL
$78.8B
$107M 0.32%
464,232
+1,787
+0.4% +$379K
FISV
68
Fiserv Inc
FISV
$29.7B
$100M 0.3%
627,216
-31,492
-5% -$4.59M
NEE icon
69
NextEra Energy
NEE
$185B
$99.1M 0.3%
1,550,481
+17,243
+1% +$1.01M
PEP icon
70
PepsiCo
PEP
$197B
$98.7M 0.3%
563,693
+23,271
+4% +$3.92M
AMT icon
71
American Tower
AMT
$80.8B
$98.4M 0.29%
497,915
+52,578
+12% +$10.5M
DHR icon
72
Danaher
DHR
$140B
$98.1M 0.29%
393,004
-17,781
-4% -$4.34M
REGN icon
73
Regeneron Pharmaceuticals
REGN
$73B
$97.4M 0.29%
101,153
-9,324
-8% -$8.87M
VRTX icon
74
Vertex Pharmaceuticals
VRTX
$124B
$96.1M 0.29%
229,891
-43,470
-16% -$18.4M
SNPS icon
75
Synopsys
SNPS
$73.5B
$93.9M 0.28%
164,391
+18,384
+13% +$10.1M

Similar funds

Axa's Q1 2024 Portfolio in Review

As of Q1 2024, Axa held 1,133 positions worth $33.4B, up 7.6% from $31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Axa's Q1 2024 filing shows 72 new, 394 increased, 425 reduced and 76 closed positions. Its largest new stake was Lamb Weston: 561,708 shares worth $59.8M. The largest sale was Axonics, Inc. Common Stock, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q1 2024 buy was Lamb Weston: 561,708 shares worth $59.8M.
  • Axa added most to Meta Platforms (Facebook) in Q1 2024, an estimated $242M increase.
  • Axa's biggest Q1 2024 reduction was Axonics, Inc. Common Stock, cutting an estimated $105M.
  • Axa fully exited Archer Daniels Midland in Q1 2024, selling an estimated $53.4M.
  • Axa's ten largest holdings make up 26% of its $33.4B portfolio in Q1 2024.
  • Axa opened 72 new positions and closed 76 in Q1 2024.
  • Axa's portfolio value rose 7.6% quarter-over-quarter to $33.4B.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.